在肺高血压中的N6-甲基氨酸修改
Yu Xia1, Yanyan Zhang2, Jie Huang3
1Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China, 17865571619@163.com.
Pharmacology
|September 24, 2023
概括
N6-甲基氨酸 (m6A) RNA甲基化对细胞功能和肺高血压至关重要. 这篇评论探讨了m6AA.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 心血管研究研究心血管研究
背景情况:
- N6-甲基氨酸 (m6A) 是真核生物中最常见的可逆RNA甲基化修饰.
- m6A通过蛋白质合成调节基本的细胞过程,包括分化,自我更新,入侵和细胞亡.
- 在肺高血压中,m6A修饰与疾病进展和肺血管重塑有关.
研究的目的:
- 审查有关肺高血压的m6ARNA甲基化研究的最新进展.
- 探索m6A修饰在肺高血压的发展和进展中的调节作用.
主要方法:
- 关于m6ARNA甲基化和肺高血压的当前研究的文献综述.
- 对调查心血管疾病中m6A调节机制的研究进行分析.
主要成果:
- m6A的修饰影响了与肺高血压相关的关键细胞过程.
- 有证据表明m6A在肺高血压的发病和进展中起着重要作用.
- m6A对肺高血压的特定影响仍未得到充分研究.
结论:
- m6ARNA甲基化是肺高血压的一个关键因素.
- 对m6A修饰的进一步研究是有必要的,以了解并可能治疗肺高血压.
相关概念视频
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Pulmonary Hypertension: Classification and Pathogenesis
207
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
207
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
177
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
177
Histone Modification
13.4K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.4K
Biosynthesis of Nucleic Acids
67
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
67
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
191
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
191


